Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B

Documenti analoghi

• Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
  di: Tyng‐Yuan Jang, et al.
  Pubblicazione: (2024)
• Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up
  di: Ming‐Whei Yu, et al.
  Pubblicazione: (2024)
• Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
  di: Yi‐Ting Chen, et al.
  Pubblicazione: (2024)
• Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
  di: Tyng‐Yuan Jang, et al.
  Pubblicazione: (2025)
• Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg‐Negative Chronic Hepatitis B
  di: Cheng‐Hao Tseng, et al.
  Pubblicazione: (2025)